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Abstract. Leishmania Viannia strains from 1,092 patients who acquired dermal leishmaniasis in endemic regions of
Colombia were analyzed for expression of species and subgenus specific epitopes. Eight monoclonal antibodies prepared
against membranes of the major species of the Viannia subgenus and previously shown to distinguish these species,
recognized low molecular mass (< 45kD) membrane components. Thirteen widely but non-uniformly distributed sero-
demes were identified: one unique to L. panamensis, four unique to L. braziliensis and eight that were common to L.
braziliensis and L. guyanensis. Thirty-seven percent of Colombian L. braziliensis strains concomitantly typed by isoen-
zymes were null, i.e., not recognized by the corresponding species-specific B-16 or B-18 antibodies. No Colombian L.
guyanensis strains were recognized by the antibody specific for this species (B-19). In contrast, L. panamensis-specific
B-4 and B11 antibodies recognized > 98% of the L. panamensis strains. Null strains of L. braziliensis and L. panamensis
were more frequently isolated from mucosal leishmaniasis than strains that expressed species specific epitopes, suggest-
ing that these strains may be more pathogenic.
INTRODUCTION
Monoclonal antibodies have proven useful in the identifi-
cation of Leishmania.1–5 Several panels of monoclonal anti-
bodies for the identification of Leishmania isolated in differ-
ent regions of the world were assembled through interna-
tional collaboration and the coordination of the World Health
Organization (WHO) Tropical Disease Research program.
Besides application in species identification, polymorphisms
in the expression of the epitopes recognized by monoclonal
antibodies may have potential in discriminating epidemiologi-
cally or biologically distinct populations. Since the epitopes
recognized as subgenus or species specific are surface mem-
brane associated,2 it is conceivable that the immune response
of the host could exert some selective pressure on their ex-
pression, and result in distinguishable populations.
Although the antibody panels have been widely evaluated
with reference strains and a large collection of strains from
Brazil,6–8 information on the reactivity of subgenus- and spe-
cies-specific antibodies for Leishmania of the Viannia subge-
nus in the Andean region has been limited. In this report, we
present the results of monoclonal antibody reactivity of more
than one thousand strains of L. Viannia from patients in re-
lation to different disease presentations and geographic dis-
tribution in Colombia. In addition, combined monoclonal an-
tibody reactivity patterns and isoenzyme polymorphisms were
used to examine intraspecies variation and the consensus be-
tween species identity based on the two phenotypic methods
in 512 of these strains.
MATERIALS AND METHODS
Leishmania strains. One thousand ninety two strains of
Leishmania that were isolated from the same number of pa-
tients who attended the Centro International de Entre-
namiento e Investigaciones Médicas (CIDEIM) in Cali, Co-
lombia between 1983 and 1995 for the diagnosis and treat-
ment of dermal leishmaniasis were included in this study.
Clinical histories including history or physical evidence of
prior leishmaniasis and epidemiologic information on expo-
sure to sand flies and acquisition of infection were obtained at
the time of consultation for diagnosis. The procedures for the
differential diagnosis and isolation of the parasites were pre-
viously described.9 Following isolation and initial propaga-
tion, isolates were cryopreserved and characterized using
monoclonal antibodies and isoenzyme electrophoresis.10,11
The WHO reference strains for L. Viannia species were
included in the characterization of patient isolates: L. pana-
mensis (MAN/PA/1971/LS94), L. braziliensis (MAN/BR/
1975/M2903), L. guyanensis (MAN/BR/1975/M4147), L. pe-
ruviana (MAN/PE/76/SL-5), and L. colombiensis (IHAR/CO/
85/CL500).
Culture conditions. Promastigotes of the reference strains
and strains isolated from patients were propagated in
Senekjie’s medium12 and/or Schneider’s Drosophila medium
(GIBCO-BRL, Gaithersburg, MD) supplemented with 10%
heat-inactivated fetal bovine serum (FBS), 1% glutamine, 100
U/ml of penicillin, and 100 g/ml of streptomycin (GIBCO-
BRL).
Cryopreservation of strains. Promastigotes were suspended
in RPMI 1640 medium (GIBCO-BRL) containing 20% heat-
inactivated FBS and 10% dimethyl sulfoxide (Fischer Scien-
tific, Pittsburgh, PA) at a concentration of 5 × 10 6/ml. Vials
were placed at −70°C overnight, then moved to storage in
liquid nitrogen. Cryopreserved material was recovered by
rapid thawing and dilution in RPMI 1640 medium containing
10% heat-inactivated FBS followed by centrifugation and re-
suspension in appropriate medium for propagation.
Indirect immunofluorescence. Promastigotes were har-
vested at 3−4 days of culture by centrifugation at 1,100 × g at
4°C for 10 min. After the parasites were washed in phosphate-
buffered saline (PBS), pH 7.2, they were counted with a he-
mocytometer and adjusted to a concentration of 1 × 107/ml in
PBS. Ten-microliter aliquots containing 1 × 104 parasites were
placed in each well of eight-well enamel-coated slides (Roboz
Instrument Co., Rockville, MD). Slides were allowed to dry at
room temperature, then fixed immediately with cold acetone
for 10 minutes, and stored at −20C until used.
Slides were blocked by incubation with PBS containing 5%
heat-inactivated fetal bovine serum for 15 minutes, then
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washed once with PBS. After drying, 10 l of monoclonal
antibody as ascitic fluid diluted 1:1,000 was added to each well
and the slides were incubated at room temperature for 30
minutes. The dilution of the monoclonal antibodies was based
on titration against WHO reference strains for the subgenus.
The panel of monoclonal antibodies used is shown in Table 1.
These antibodies reactive with species pertaining to the bra-
ziliensis complex of Leishmania, now referred to as the Vian-
nia subgenus, have been previously described.1,2 The slides
were then washed three times with PBS and allowed to dry at
room temperature before incubating with fluorescein-
conjugated goat anti mouse IgG (10 L/well) at a dilution of
1:50 (Kirkegaard and Perry Laboratories, Inc., Gaithersburg,
MD). Following three washes with PBS and drying at room
temperature, the slides were mounted using 90% glycerol in
PBS. Fluorescence was evaluated using a Leitz Wetzlar Di-
alux microscope with KP490 exciter and K510 and BG38 sup-
pression filters (E. Leitz, Rock-Leigh, NJ). Results were re-
corded as ++, intense fluorescence of 100% of the promas-
tigotes; +, well-defined fluorescence of 100% of the
promastigotes; +−, weak reactivity of a variable proportion of
the promastigotes; and − , no fluorescence.
Western blot analysis. Promastigote membranes were iso-
lated using nitrogen cavitation and differential centrifugation
as described13 and proteins were separated by sodium dodec-
yl sulfate−polyacrylamide gel electrophoresis. Proteins were
transferred electrophoretically onto nitrocellulose according
to the method of Towbin and others14 and processed as pre-
viously described.15
RESULTS
Western blot analyses of Leishmania (Viannia) membrane
preparations using subgenus- and species-specific monoclonal
antibodies. The membrane proteins recognized by the L. bra-
ziliensis- and/or L. panamensis-specific monoclonal antibod-
ies were identified by Western blot analyses (Figure 1). The
components recognized were all low molecular mass (< 45
kD). In the case of L. panamensis, some of the monoclonal
antibodies appeared to recognize similar membrane compo-
nents (i.e., antibodies B-4 and B-11, and B-5 and B-21). These
results were consistent with known specificities of these sets
of antibodies, which are specific for L. panamensis, and L.
braziliensis/L. panamensis, respectively. Notably, antibodies
specific for each species (i.e., B-4 and B-11 for L. panamensis
and B-16 and B-18 for L. braziliensis) did not cross-react with
the other species.
Antibody reactivity profile by species and zymodeme. Se-
rodemes were defined based upon a unique pattern of reac-
tivity with the panel of monoclonal antibodies (Table 2). The
pattern of monoclonal reactivity of L. panamensis strains was
essentially homogeneous. All but six of 906 strains of L. pana-
mensis isolated from patients, as well as the WHO reference
strain for the species MHOM/PA/71/LS94, reacted with spe-
cies-specific monoclonal antibodies B4 and B11 and subge-
nus-reactive antibodies B2 and B21 by indirect immunofluo-
rescence, (Serodeme 1) (Table 2). Five of the six L. pana-
mensis strains that failed to react with the species-specific
antibodies reacted with at least one subgenus-specific anti-
body. Most of the limited heterogeneity in monoclonal anti-
body reactivity of this species was found in a single zymodeme
(2.3) (Table 3).
In contrast with L. panamensis, the Colombian L. brazilien-
sis strains displayed nine different reactivity profiles or sero-
demes using the monoclonal antibody panel. Four of these,
2a, b, c, and d (Table 2) were unique to L. braziliensis strains;
2a was predominant. Eight serodemes were observed within a
single L. braziliensis zymodeme (1.1) (Table 3). Thirty-seven
(41%) of 91 L. braziliensis strains also typed by isoenzymes
showed the same pattern of reactivity as the WHO reference
strain for L. braziliensis (MHOM/BR/75/M2903) and were
reactive with the species specific-antibodies B16 and B18 (Se-
rodeme 2a) (Table 3). Thirty-four (37%) of the Colombian L.
braziliensis strains classified in four of seven zymodemes
failed to react with these species-specific antibodies.
Colombian strains of L. guyanensis were not reactive with
the species-specific antibody B19 under the indirect floure-
scent antibody test conditions used. Three reactivity profiles
with the monoclonal antibody panel were observed for this
species: serodemes 3a, 3b, and 8. Most strains of L. guyanensis
belonged to serodeme 3b, which was defined by reactivity
with antibodies B2 and B12. Reactivity with monoclonal an-
tibody B21 was infrequent. As observed for the other species
of the Viannia subgenus, no serodeme of L. guyanensis was
restricted to any particular zymodeme.
None of the 1,092 strains belonging to the Viannia subge-
nus reacted with monoclonal antibodies that recognize L.
donovani (D2), or L. mexicana/L. amazonensis (M-7), con-
firming the specificity of the latter antibodies.
Geographic distribution of serodemes. Serodemes 1 (L.
panamensis) and 2a (L. braziliensis) were prevalent through-
out the hydrographic regions of Colombia (Figure 2 and
Table 4). The Pacific coast region (constituted by the Atrato,
San Juan, Patía, and Mira River basins), which is the pre-
dominant source of cases that attend the CIDEIM, yielded
strains of L. Viannia having 11 different reactivity profiles
with the panel of monoclonal antibodies. All but three of
these, serodemes 2c, 5, and 9, have been found among strains
from other hydrographic regions. Ten serodemes were iden-
tified among strains from the Amazon river basin and two of
these, 2d and 8, were only observed among strains from this
hydrographic region.
The distribution of strains that were non-reactive with spe-
cies-specific monoclonal antibodies was not uniform. Sev-
enty-four percent (42 of 57) of the strains originating in the
TABLE 1




L. Viannia subgenus VI-4B9-D10 B-2
L. Viannia subgenus XLIV-5H2-A10 B-13
L. panamensis/L. braziliensis XIII-3H6-A12 B-12
L. panamensis/L. guyanensis VII-6H9-G10 B-21
L. panamensis/L. braziliensis VII-2C5-C5 B-5
L. panamensis/L. braziliensis/
L. colombiensis VII-3E12-D3 B-8
L. panamensis VI-2A5-A4 B-4
L. panamensis VII-5G3-F3 B-11
L. braziliensis XIII-3E6-B11 B-16
L. braziliensis XIV-2A5-A10 B-18
L. guyanensis XLIV-5A2-B9 B-19
L. donovani LXXVIII-2E5-A8 D-2
L. mexicana/L. amazonensis LXVIII-1D7-B8 M-7
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Amazon River basin were non-reactive with species-specific
monoclonal antibodies, whereas in the two other hydro-
graphic regions from which a substantial number of strains
had originated (Atrato and San Juan, and Patía and Mira
River basins) only 5.2% of 267 and 4.5% of 726 strains, re-
spectively, were non-reactive (Table 4). Leishmania guyanen-
sis constituted approximately 75% of the non-reactive strains
from the Amazon River basin and L. braziliensis 25%, while
L. braziliensis predominated among the non-reactive strains
from the river basins of the Pacific coast region.
Colombian strains compared with L. Viannia species from
neighboring countries. The strains of L. peruviana and L. bra-
ziliensis from Peru that were examined were found to react
with L. braziliensis-specific antibodies B16 and B18, as well as
subgenus-specific antibodies B12 and B2, a pattern corre-
sponding with Colombian serodeme 2a. However, as found
among many Colombian strains, reactivity with B16 was weak
for some strains of L. braziliensis from Peru. The Peruvian
strains of L. braziliensis and L. peruviana varied in their re-
activity with antibody B21. Reference strains for L. colombi-
ensis and L. ecuatorensis did not react in the indirect IFAT
assay using this panel of monoclonal antibodies for Leishma-
nia Viannia. The profiles of isoenzyme polymorphisms of
these two species were distinct from those of the more than
TABLE 2
Reactivity of Colombian Leishmania Viannia with subgenus- and species-specific monoclonal antibodies*
Specificity†
antibody designation



















Reference strains L. Viannia
LS 94 (L. V. panamensis) ++ − − − ++ ++ − ++ −
M4147 (L. V. guyanensis) − − − + + − ++ − −
M2903 (L. V. braziliensis) − ++ ++ − ++ ++ ++ − −
Colombian serodeme
1 ++ − − − ++ ++ − ++ 900
2 a − ++ ++ − ++ ++ ++ − 82
b − − + − ++ ++ ++ − 9
c − − + − ++ ++ − − 5
d − − + − ++ − ++ − 1
3 a − − − − ++ ++ ++ − 25
b − − − − ++ − ++ − 32
4 − − − − − − + − 6
5 − − − − +/− + +/− +/− 7
6 − − − − − + + − 11
7 − − − − − − − − 10
8 − − − + − − − 2
9 − − − − + + − − 2
Total 1,092
* ++  intense fluorescence (100%); +  well-defined fluorescence; +/−  weak fluorescence variable %; −  no fluorescence.
† Lp  L. panamensis; Lb  L. braziliensis; Lg  L. guyanensis; LV  L. Viannia subgenus.
FIGURE 1. Western blot analyses of membrane preparations of A, Leishmania panamensis and B, L. braziliensis promastigotes using mono-
clonal antibodies. Lane 1, M-7 (LXVII-ID7-B8; negative control); lane 2, B-4 (VI-2A5-A4); lane 3, B-2 (VI-4B9-D10); lane 4, B-5 (VII-2C5-C5);
lane 5, B-11 (VI-5G3-F3); lane 6, B-21 (VII-6H9-G10); lane 7, B-16 (XII-3E6-B11); lane 8, B-12 (XIII-3H6-A12); lane 9, B-18 (XIV-2A5-A10);
lane 10, B-19 (XLIV-5A2-B9). Values on the right of each blot are molecular mass (Mr) values in kilodaltons (kDa).
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TABLE 3
Serodemes identified among Colombian Leishmania Viannia species and zymodemes using a monoclonal antibody panel for the Viannia subgenus
Zymodeme
L. V. braziliensis L. V. panamensis L. V. guyanensis
1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 2.0 2.1 2.2 2.3 2.4 2.5 3.0 3.1 3.2 Total
Serodeme
1 41 184 159 8 1 393
2 a 15 26 1 42
b 7 1 1 9
c 5 5
d 1 1
3 a 17 1 1 1 20
b 2 1 3 2 1 4 4 11 28
4 2 1 1 1 1 6
5 2 2
6 1 1 2
7 1 1
8 1 1 2
9 1 1
Total/zymodeme 50 1 1 2 32 2 3 42 184 164 8 1 5 4 13 512
Total/species 91 399 22 512
Frequency (%) 17.8 77.9 4.3 100
FIGURE 2. Map of hydrographic regions of Colombia showing the Leishmania Viannia species distribution based on monoclonal antibody
typing. Leishmania panamensis has been identified among isolates from patients reporting acquisition of infection in the states of Putumayo,
Caqueta and Guaviare within the Amazon River Basin.
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500 strains of L. panamensis, L. guyanensis, and L. brazilien-
sis evaluated by both typing methods.
Relationship between antibody reactivity and clinical out-
come of infection. The frequency of mucosal disease was
higher among L. braziliensis and L. panamensis strains that
were non-reactive with species-specific monoclonal antibod-
ies than among strains that expressed these epitopes (Figure
3). This association of a null phenotype with mucosal disease
was observed for both L. panamensis and L. braziliensis, al-
though it was statistically significant only for L. panamensis
(P  0.029). Cutaneous and mucosal isolates (seven pairs)
from the same patients were not distinguishable with respect
to monoclonal antibody reactivity profile. Lymphadenopathy,
time of evolution, recurrent lesions, and size or number of
lesions were not correlated with Leishmania phenotype based
on reactivity with this monoclonal antibody panel.
DISCUSSION
Conservation of the reactivity profile including species-
specific B4 and B11 antibodies among strains of L. panamen-
sis from a wide geographic range contrasts with the high vari-
ability of the pattern of monoclonal antibody reactivity of L.
braziliensis. The marked disparity in heterogeneity of these
two species was also evident as isoenzyme polymorphisms,11
and is even more striking in the expression of membrane
antigen determinants recognized by monoclonal antibodies.
Grimaldi and others6 initially found the reactivity of L. bra-
ziliensis strains to the species-specific B16 and B18 antibodies
to be conserved among strains examined from Brazil, Ven-
ezuela, and Central America, but not among the strains ex-
amined from Peru. Subsequent analyses of Leishmania iso-
lates from the Amazon region of Brazil revealed variable
reactivity of some strains of L. braziliensis with the B16 an-
tibody and L. guyanensis strains that did not react with the
species-specific B19 antibody.8 Since the type strain used to
produce the L. braziliensis-specific antibodies is a reference
strain originating in Brazil, the divergence of epitope expres-
sion among strains from the Andean region could result from
geographic isolation of some populations of L. braziliensis.
However, geographic isolation does not seem to explain the
distribution of L. braziliensis strains that do not react with
species-specific antibodies since Colombian Leishmania lack-
ing the species-specific epitopes or null phenotype originated
from the Amazon River basin as well as the Pacific coast, i.e.,
regions separated by three ranges of the Andes mountains.
On the other hand, human migrations could in effect reduce
or eliminate the isolation imposed by geographic barriers to
the dispersal of vector populations and sylvatic mammalian
reservoirs. Also, because the frequency of non-reactivity
with species-specific antibodies differed among the species of
L. Viannia, the prevalence of different species in different
regions clearly influenced the overall proportion of null
strains.
TABLE 4























1 187 672 11 12 4 10 4 900
Species-specific a 66 8 1 3 3 1 82
serodemes 2 b 8 1 9
c 5 5
d 1 1
Subtotal by region 253 693 12 15 4 15 5 997
% Reactive by region 94.8 95.5 92.3 88.2 57.1 22.8 100.0 91.3
3 a 4 16 1 1 3 25
b 1 3 1 1 1 25 32
4 2 1 3 6
Null 5 3 4 7
serodemes 6 3 5 3 11
7 3 1 6 10
8 2 2
9 2 2
Subtotal by region 14 33 1 2 3 42 0 95
% Null by region 5.2 4.5 7.7 11.8 42.9 73.7 0 8.7
Total 267 726 13 17 7 57 5 1092
Frequency (%) 24.4 66.5 1.2 1.6 0.6 5.2 0.5 100.0
FIGURE 3. Frequency of mucosal disease in relation to reactivity
of Colombian strains of Leishmania braziliensis and L. panamensis
with species-specific monoclonal antibodies for L. braziliensis (B-16
and/or B-18) and L. panamensis (B-11). *P  0.029, by Fisher’s test.
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The diversity of (10) and predominance of null phenotypes
among the 57 strains of L. Viannia from the southwestern
departments of Colombia within the Amazon River basin
(Putumayo, Caquetá, and Guaviari) is noteworthy. This re-
gion also presented the highest diversity of zymodemes of L.
braziliensis (5) and L. guyanensis (4) compared with all other
hydrographic regions of Colombia.11 Similarly, 15 L. bra-
ziliensis strains from the Brazilian Amazon were found to be
highly polymorphic, constituting seven zymodemes and five
serodemes.8 Genetic divergence of Lutzomyia shannoni
populations present in the Amazon basin from other popula-
tions of this zoophilic species has recently been reported.16
Although the role of this sand fly species, the most wide-
spread in the Americas, in the transmission of Leishmania of
the Viannia subgenus is unknown, genetic divergence of a
vector species could be expected to be accompanied by ge-
netic differences in the parasites that they transmit.
Up until 1990 no one had previously identified L. pana-
mensis among isolates from individuals who reported acquir-
ing infection in the Amazon river basin.11,17 In this study, a
cluster of 10 strains, nine isolated from soldiers and one from
a farmer who reported acquisition of infection between 1990
and 1993 in diverse sites in the states of Putumayo and
Caquetá, were identified as L. panamensis. Considering the
mobility and repeated exposure of military personnel to dif-
ferent endemic foci, we cannot be certain whether the infec-
tions may have been acquired elsewhere, were introduced by
movements of human populations,8,18 or indicate an endemic
focus of L. panamensis in a region where L. braziliensis and
L. guyanensis predominate. Thus, the influence of geographic
isolation on genotypic and phenotypic markers may be more
difficult to discern in settings characterized by intense human
migratory activity as has occurred in Colombia during the last
decade.
The possibility that strains of L. Viannia that did not react
with species-specific antibodies were L. colombiensis or L.
ecuatorensis was ruled out by the unique isoenzyme profiles
of the latter species. The non-reactivity of the reference
strains in this analysis using the IFAT with antibodies B4, B8,
or B13 contrasts with findings reported using a radioimmu-
noassay (RIA) in the original description of these species.19,20
This discrepancy could be due either to the lower sensitivity
of the IFAT or differences in access to the epitopes in mem-
brane preparations used in RIA compared with intact pro-
mastigotes used in the IFAT.
The enzymes evaluated for polymorphisms detectable as
charge isoforms are constitutive gene products, whereas the
antigen determinants detected by monoclonal antibodies,
which are variably expressed, evidently are not constitutive.
Non-essential gene products could be expected to show
greater variability since mutations or epigenetic changes
could accumulate without lethal consequences, and would be
conserved if they provided some selective advantage. There-
fore, the conserved expression of cell membrane antigen de-
terminants that distinguish L. panamensis from other species
of Leishmania is noteworthy. Conversely, the conservation of
serologically recognized determinants in strains isolated from
the same patient after relapse of disease or metastasis from
cutaneous to mucosal sites suggests that the host immune
response does not alter the expression of these determinants.
This could be explained by the fact that these antigens are
expressed on the promastigote stage, and the host is predomi-
nantly exposed to the amastigote stage.
Alternatively, the association of mucosal disease with
strains that lacked species-specific epitopes (null strains)
raises the possibility that these strains are more likely to me-
tastasize and colonize mucosal tissue. Examination of several
null mucosal strains by RIA corroborated the absence of the
corresponding epitopes.10 The heterogeneous reactivity of a
secondary panel of eight monoclonal antibodies prepared
against one of the null strains of L. braziliensis (Man/CO/84/
L-87), when used to examine B16/B18 positive and null
strains of the same species, did not identify an epitope unique
to null strains, or common to L. braziliensis strains that either
lacked or expressed the species-specific epitopes. Conceiv-
ably, the absence of epitopes common to most strains of a
species could influence the host response and thus the out-
come of infection. The phenotypic differences may be mark-
ers of biologic differences or could themselves be functionally
involved in the biology of the host-parasite relationship. The
present results suggest an association between the lack of
these epitopes and mucosal disease and, allow and the for-
mulation of the hypothesis that null strains may be more
pathogenic. Experimental studies are required to address this
hypothesis.
The determinants recognized by monoclonal antibodies
B-4, B-11 and B-16, B-18 appear to be completely specific for
L. panamensis and L. braziliensis, respectively. This is in con-
trast to certain other species-specific determinants of L. dono-
vani, the L. mexicana complex and L. major,3–5 which are not
exposed on immunofluorescence or radioimmune binding as-
says using either whole organisms or isolated membrane
preparations, but become accessible upon solubilization with
detergent. However, given the similar molecular masses of
the molecules associated with the determinants recognized by
B-21 (L. panamensis/L. braziliensis specific) and B-18 (L.
braziliensis-specific) it is not clear whether these epitopes
might be associated with the same molecules. The general
conservation of these epitopes in the respective species and
their apparent association on similar molecules suggest that
these molecules may have an important biologic function.
Nevertheless, further work is needed to clarify the molecular
relationship among these epitopes and their biologic signifi-
cance.
The use of monoclonal antibodies for typing by IFAT is
simple and efficient for strains that are reactive with the spe-
cies-defining antibodies. In the Andean region, it can be an-
ticipated that a proportion of L. guyanensis and L. braziliensis
strains will not be identified to the species level with the
existing panel and additional methods such as the polymerase
chain reaction21 or isoenzymes will be needed to establish
species identity. Notwithstanding this qualification, the panel
of monoclonal antibodies is highly useful for identifying the
majority of isolates, and in areas of South America where
some strains do not react with species-specific monoclonal
antibodies, this tool provides an efficient first screening
method.
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